+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Platelet Rich Plasma Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon


  • 181 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5650823

Increasing research applications of platelet rich plasma (PRP) are fueling the industry growth

The Global Platelet Rich Plasma Market is estimated to be USD 332.26 Mn in 2022 and is expected to reach USD 613.25 Mn by 2027, growing at a CAGR of 13.04%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Platelet Rich Plasma Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Platelet Rich Plasma Market is segmented based on Product Type, Source Type, Application, and Geography.
  • By Product Type, the market is classified into Pure PRP, Leukocyte Rich PRP and Leukocyte Rich Fibrin.
  • By Source Type, the market is classified into Allogenic, Autologous and Homologous.
  • By Application, the market is classified into Cosmetic Surgery, General Surgery, Neurosurgery and Orthopedic Surgery.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are APEX Biologix, LLC, Arthrex, Inc., Biotest Ag, Becton, Dickinson and Company, Celling Biosciences, Inc., Dr PRP USA, LLC, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Platelet Rich Plasma Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Platelet Rich Plasma Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Platelet Rich Plasma Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Incidences of Sports-related Injuries Global ly
4.1.2 Potential Application in the Treatment of Musculoskeletal Conditions and Orthopedic Disorders
4.1.3 Increasing use in Cosmetic Surgery and for Natural Healing Process
4.2 Restraints
4.2.1 Uncertainty on Therapeutic Efficacy of Platelet Rich Plasma
4.3 Opportunities
4.3.1 Emerging Application in Regenerative Medicine
4.3.2 Ongoing Research and Development Activities on Platelet-Rich Plasma Derived Bioactive Molecules
4.4 Challenges
4.4.1 Limited Availability of Clinical Trials and Reimbursement Policies of Platelet-rich Plasma Products
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Platelet Rich Plasma Market, By Product Type
6.1 Introduction
6.2 Pure PRP
6.3 Leukocyte Rich PRP
6.4 Leukocyte Rich Fibrin
7 Global Platelet Rich Plasma Market, By Source Type
7.1 Introduction
7.2 Allogenic
7.3 Autologous
7.4 Homologous
8 Global Platelet Rich Plasma Market, By Application
8.1 Introduction
8.2 Cosmetic Surgery
8.3 General Surgery
8.4 Neurosurgery
8.5 Orthopedic Surgery
9 Americas’ Platelet Rich Plasma Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Platelet Rich Plasma Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Platelet Rich Plasma Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Platelet Rich Plasma Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 APEX Biologix, LLC
14.2 Arthrex, Inc.
14.3 Biotest Ag
14.4 Becton, Dickinson, and Company
14.5 Celling Biosciences, Inc.
14.6 Dr PRP USA, LLC
14.7 Eclipse
14.8 EmCyte Corp.
14.9 Estar Technologies, Ltd.
14.10 Exactech, Inc.
14.11 F. Hoffmann-La Roche, Ltd.
14.12 Johnson & Johnson
14.13 Juventix Regenerative Medical, LLC
14.14 Stryker Corp.
14.15 Terumo BCT, Inc.
14.16 Zimmer Biomet Holdings, Inc.
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • APEX Biologix, LLC
  • Arthrex, Inc.
  • Biotest AG
  • Becton, Dickinson, and Company
  • Celling Biosciences, Inc.
  • Eclipse
  • EmCyte Corp.
  • Estar Technologies, Ltd.
  • Exactech, Inc.
  • F. Hoffmann-La Roche, Ltd.
  • Johnson & Johnson
  • Juventix Regenerative Medical, LLC
  • Stryker Corp.
  • Terumo BCT, Inc.
  • Zimmer Biomet Holdings, Inc.

Table Information